Shanghai, China (PressExposure) June 05, 2009 -- Shanghai, the next seedbed for future discoveries, welcomes you to come and feel the pulse of the world's fastest growing CRO marketplace. InterContinental Shanghai Pudong PRC...September 16th - 18th, 2009...will welcome the opening of the World Pharmaceutical (China) Summit 2009(WPCS2009), expectedly a grand gathering of 300+ senior level executives from global pharmaceutical fraternity in China and elsewhere around the world. Delegates from all sectors of the pharmaceutical industry, including big pharmas; biotech companies; CROs; major hospitals; technology / equipment providers;capital owners, lawyers etc are attending and the swell of interest in this meaningful event has been remarkable!
WPCS2009 boasts great support from CAP, SAPA, JPMA, Bayer, GSK, Roche, MSD, Eli Lilly, Pfizer, Johnson & Johnson, Kirin Pharmaceutial Novo Nordisk, Sanofi-Aventis, Takeda, Eisai, Abbott Laboratories, Novasep, DSM, Quintiles, PPD, Covance, Chemon, WuXi Pharma Tech, Sundia; ChemPartner, GenScript Corporation, FosunPharma, Hutchison MedPharma, Shanghai Pharmaceutical Group, North China Pharmaceutical Corporation, etc, featuring the official guideline presentations from Ministry of Health, PRC and State Intellectual Property Office, PRC.
WPCS2009 is one of the major international functions that link pharma executives from all over the world together. The theme of WPCS2009 on "Finding the Next Blockbuster and Turning Crisis into Opportunity" is particularly important to pharmaceutical MNCs striving for international cooperation for further growth. WPCS2009 will provide the most integrated platform for partnerships at both a strategic & technical level, and it will influence the whole China, even global pharmaceutical industry with positive and strong stimulation, herewith save the dates of September 16-18 on your 2009 calendar & secure your interest today!